Re: Surgery in Early Metastatic Seminoma: A Phase II Trial of Retroperitoneal Lymph Node Dissection for Testicular Seminoma with Limited Retroperitoneal Lymphadenopathy

Affiliations

¹ E.J. Whitten Prostate Cancer Research Centre, Epworth Healthcare, Melbourne, Australia; Department of Surgery, Royal Melbourne Hospital, University of Melbourne, Melbourne, Australia.
² Department of Surgery, Royal Melbourne Hospital, University of Melbourne, Melbourne, Australia.
³ E.J. Whitten Prostate Cancer Research Centre, Epworth Healthcare, Melbourne, Australia; Department of Surgery, Royal Melbourne Hospital, University of Melbourne, Melbourne, Australia; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia. Electronic address: lawrentschuk@gmail.com.

Comment

Jianliang Liu et al. Eur Urol. 2023 Oct.

. 2023 Oct;84(4):438-439.

doi: 10.1016/j.eururo.2023.05.025. Epub 2023 Jun 27.

¹ E.J. Whitten Prostate Cancer Research Centre, Epworth Healthcare, Melbourne, Australia; Department of Surgery, Royal Melbourne Hospital, University of Melbourne, Melbourne, Australia.
² Department of Surgery, Royal Melbourne Hospital, University of Melbourne, Melbourne, Australia.
³ E.J. Whitten Prostate Cancer Research Centre, Epworth Healthcare, Melbourne, Australia; Department of Surgery, Royal Melbourne Hospital, University of Melbourne, Melbourne, Australia; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia. Electronic address: lawrentschuk@gmail.com.

No abstract available

Comment on

Surgery in Early Metastatic Seminoma: A Phase II Trial of Retroperitoneal Lymph Node Dissection for Testicular Seminoma With Limited Retroperitoneal Lymphadenopathy.
Daneshmand S, Cary C, Masterson T, Einhorn L, Adra N, Boorjian SA, Kollmannsberger C, Schuckman A, So A, Black P, Bagrodia A, Skinner E, Alemozaffar M, Brand T, Eggener S, Pierorazio P, Stratton K, Nappi L, Nichols C, Luo C, Li M, Hu B. Daneshmand S, et al. J Clin Oncol. 2023 Jun 1;41(16):3009-3018. doi: 10.1200/JCO.22.00624. Epub 2023 Mar 13. J Clin Oncol. 2023. PMID: 36913642 Clinical Trial.